Pavic M, Le Pape E, Debourdeau P, Rabar D, Crevon L, Colle B, Rousset H
Service de médecine interne-oncologie, hôpital d'instruction des armées Desgenettes, 108 boulevard Pinel, Lyon, France.
Rev Med Interne. 2008 Jan;29(1):5-14. doi: 10.1016/j.revmed.2007.05.028. Epub 2007 Jun 21.
Systemic granulomatosis (SG) are frequently encountered in internal medicine. Despite a large list of aetiologies, the investigations remain often negative leading to the diagnosis of atypical sarcoidosis. The spectrum of the causes, as well as evolution of these SG is not clearly delineated in the literature.
We analyzed the case reports of all but tuberculous GS submitted at the National Meetings of the National French Society of Internal Medicine from 1990 to 2006.
Sixty-seven cases were included in the study. The average age at the beginning of the symptoms was 47.8 years and 28.4% of the patients were female. The median diagnostic delay was one year. General symptoms were present in 73.1% of the cases. The involved organs were the liver (46.3%), lungs (25.4%), lymph nodes (22.4%), digestive tract (16.4%), skin (16.4%), spleen (14.9%). The granuloma were detected mainly in the liver (38.8%), lymph nodes (17.9%), bone marrow (16.4%) and lungs (11.9%). Elevated erythrocyte sedimentation rate or increased C reactive protein serum levels were noted in 65.6% of the patients. Before diagnosis, 19.4% of the patients received a corticotherapy. The most common diagnoses were infections (65.6%) followed by drugs (19.5%), "toxic substances" or various foreign bodies (5.9%), neoplasias (5.9%) and immune deficiencies (3%). The evolution was favourable in 80% of the cases but 8.3% of the patients died. The disease course of the patients having received a corticotherapy prior to the diagnosis was more unfavourable with a death rate of 45%.
In atypical sarcoidosis (fever, advanced age, increased acute phase reactants...) a specific aetiology and especially an infectious disease should be ruled out before considering the diagnosis of sarcoidosis. Corticotherapy is a factor of poor prognosis.
系统性肉芽肿病(SG)在内科中经常遇到。尽管病因众多,但检查结果往往为阴性,导致诊断为非典型结节病。这些SG的病因范围以及演变在文献中并未明确界定。
我们分析了1990年至2006年在法国全国内科协会年会上提交的除结核性GS外的所有病例报告。
该研究纳入了67例病例。症状出现时的平均年龄为47.8岁,28.4%的患者为女性。中位诊断延迟为1年。73.1%的病例出现全身症状。受累器官包括肝脏(46.3%)、肺(25.4%)、淋巴结(22.4%)、消化道(16.4%)、皮肤(16.4%)、脾脏(14.9%)。肉芽肿主要在肝脏(38.8%)、淋巴结(17.9%)、骨髓(16.4%)和肺(11.9%)中检测到。65.6%的患者红细胞沉降率升高或C反应蛋白血清水平升高。诊断前,19.4%的患者接受了皮质激素治疗。最常见的诊断是感染(65.6%),其次是药物(19.5%)、“有毒物质”或各种异物(5.9%)、肿瘤(5.9%)和免疫缺陷(3%)。80%的病例病情好转,但8.3%的患者死亡。诊断前接受皮质激素治疗的患者病程更差,死亡率为45%。
在非典型结节病(发热、高龄、急性期反应物升高……)中,在考虑结节病诊断之前,应排除特定病因,尤其是传染病。皮质激素治疗是预后不良的一个因素。